The global refrigerated vehicles market reached USD 128.7 billion in 2025. It is on track for a compound annual growth rate of 6.44% through 2034, when value reaches USD 224.9 billion, with 2026 already priced at USD 136.5 billion. Contrive Datum Insights sets out these figures in a report titled "Refrigerated Vehicles Market Size, Share & Industry Analysis, By Type (Refrigerated Trucks, Refrigerated Trailers, Refrigerated Vans, Refrigerated Ships, Refrigerated Railcars, Other), Application (Vulnerable Food Transportation, Pharmaceutical Products Transportation, Healthcare Products Transportation, Other), Technology (Vapor Compression System, Cryogenic/Eutectic System, Hybrid/Electric-Driven System), Temperature range (Single-Temperature, Multi-Temperature), Sales channel (OEM, Aftermarket), and Regional Forecast, 2026-2034".
The category covers trucks, vans, trailers, railcars and marine vessels built or retrofitted with temperature-controlled cargo space, cooled by mechanical vapor compression, cryogenic or eutectic systems. Buyers span food and beverage distributors, grocery chains, pharmaceutical and healthcare logistics providers, third-party cold chain operators and fleet lessors moving goods that cannot leave a set temperature band between origin and destination. Some of that volume is refrigeration equipment fitted onto chassis and trailers that already exist, not only new vehicle purchases.
The single largest contributor to growth through 2034 is the expansion of e-commerce and last-mile cold chain delivery, rated a high-impact driver in the study. Refrigerated Vans sit closest to that demand and compound at 9.08% a year, well ahead of the market's 6.44% average; their share of revenue climbs from 20% in 2025 to 25% in 2034 as value rises from USD 25.74 billion to USD 56.23 billion.
Refrigerated Trucks remain the largest type line, holding 34% of 2025 revenue at USD 43.76 billion and 33% by 2034, even as their own growth rate of 6.09% trails the category average. By application, Vulnerable Food Transportation accounts for 62% of 2025 revenue (USD 79.79 billion), while Pharmaceutical Products Transportation expands fastest, at 9.29%. Vapor Compression Systems supply 72% of 2025 revenue (USD 92.66 billion) on the technology axis, but Hybrid/Electric-Driven Systems grow quickest, at 13.58%. Single-Temperature units hold 68% of 2025 revenue (USD 87.52 billion) against Multi-Temperature's faster 9.07% growth, and OEM sales account for 78% of 2025 revenue (USD 100.39 billion) while the Aftermarket grows faster, at 8.4%.
Asia Pacific is the largest region, with 34% of 2025 revenue (USD 43.76 billion) climbing to 38% by 2034 (USD 85.46 billion). Middle East and Africa stays the smallest region across the period, moving from 7% to 8%. The United States is the largest single country market at USD 27.1 billion in 2025, 21.06% of global revenue, a scale no other individual country in the study approaches.
The forecast has boundaries as well as a midpoint. If fleet electrification and regulation-driven replacement cycles arrive faster than assumed, and pharmaceutical cold chain volumes grow beyond the base case as more biologics require controlled transport, 2034 revenue could reach USD 247.39 billion instead of USD 224.9 billion. If fuel and financing costs stay elevated long enough to delay fleet renewal, and cold chain infrastructure build-out in emerging markets proceeds more slowly than currently planned, the same year could land at USD 202.41 billion instead. Either shift turns on the same two variables: how quickly fleets turn over, and how quickly temperature-controlled infrastructure reaches markets that do not yet have it.